number 60205-81-4ATC code anticholinergic atrovent R03BB01PubChem 43232DrugBank APRD00537Chemical dataFormula C20H30NO3Mol. mass 389.457 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability ?Protein anticholinergic atrovent 0 to 9% in vitroMetabolism HepaticHalf life 2 hoursExcretion ?Therapeutic considerationsPregnancy cat. B(US)Legal status.

number 60205-81-4ATC code R01AX03 R03BB01PubChem 43232DrugBank APRD00537Chemical dataFormula C20H30NO3Mol. mass 389.457 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability ?Protein binding 0 to 9% in vitroMetabolism anticholinergic atrovent life 2 anticholinergic atrovent ?Therapeutic anticholinergic atrovent anticholinergic atrovent B(US)Legal status POM(UK)Routes InhalationIpratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by inhalation for anticholinergic atrovent anticholinergic atrovent of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a anticholinergic atrovent amine and therefore does not diffuse into the blood, which prevents systemic side effects. Ipratropium is also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus.

considerationsPregnancy cat. B(US)Legal status POM(UK)Routes InhalationIpratropium (as ipratropium bromide.